Notícias CytomX Therapeutics Inc - CTMX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
CytomX Therapeutics Inc (CTMX)
CytomX Therapeutics Inc (CTMX) Notícias

CytomX Therapeutics Inc (CTMX)

0,632

-0,0208

( -3,19% )

Atualizado: 16:25:30

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Form 8-K - Current report

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Form 8-K - Current report

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

CytomX Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições